GlassScriptPhysician profile
Michael A Haughey
NPI 1861436875
$4,635.00
in general payments reported to CMS, 2019-2025
20 companies · $50.95 in 2025
The $50.95 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,880 · 2020: $46.73 · 2021: $225 · 2022: $389 · 2023: $21.00 · 2024: $21.98 · 2025: $50.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $93.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $93.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Midsouth Orthopedics INC. | $3,024.59 | 2019-2022 | |
| Stryker Corporation | $1,044.95 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $85.78 | 2019 | |
| Djo, LLC | $80.70 | 2021 | |
| Treace Medical Concepts, INC. | $58.62 | 2022 | |
| Organogenesis INC. | $55.74 | 2021-2022 | |
| In2bones USA, LLC | $35.77 | 2019 | |
| Orthofix Medical, INC. | $33.15 | 2019-2023 | Physio-Stim |
| Kerecis Limited | $27.87 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Amgen INC. | $25.52 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $23.08 | 2025 | |
| Averitas Pharma INC. | $21.98 | 2024 | Qutenza |
| Smith+Nephew, INC. | $20.63 | 2020 | |
| Bioventus LLC | $16.06 | 2021 | |
| Horizon Therapeutics Plc | $15.33 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $15.08 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.96 | 2022 | |
| Grt US Holding, INC. | $12.93 | 2021 | |
| Triad Life Sciences INC. | $12.45 | 2021 | |
| Melinta Therapeutics, LLC | $11.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Haughey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.